{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:07:10Z","timestamp":1794344830690,"version":"4.9.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our recent genome-wide association study found that the <jats:italic>NELFCD<\/jats:italic>\/<jats:italic>CTSZ<\/jats:italic> locus was significantly associated with progression of primary biliary cholangitis (PBC) to jaundice stage in the Japanese population. In this study, we investigated the role of cathepsin Z in the etiology and pathology of PBC. Serum cathepsin Z levels were measured using enzyme-linked immunosorbent assay. The expression and localization of cathepsin Z in liver specimens were analyzed by western blotting and immunohistochemistry. In PBC patients, serum cathepsin Z levels were significantly increased with disease progression. In addition, its levels were positively correlated with alanine transaminase, aspartate transaminase and total bilirubin, and were negatively correlated with platelet count and albumin. Cathepsin Z expression was markedly increased in hepatocytes at later stages of PBC, and its localization was altered from the peri-bile canaliculus to the cytoplasm, where a fraction was no longer colocalized with endosomal\/lysosomal vesicles. Similar altered expression of cathepsin Z was observed in end-stage of other cholestatic liver diseases including sepsis, obstructive jaundice, and Alagille syndrome. Our results indicate that altered expression and localization of cathepsin Z in hepatocytes are characteristic features of PBC and other cholestatic liver diseases, and are implicated in the progression of PBC.<\/jats:p>","DOI":"10.1038\/s41598-018-30146-w","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:54:48Z","timestamp":1533117288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased expression and altered localization of cathepsin Z are associated with progression to jaundice stage in primary biliary cholangitis"],"prefix":"10.1038","volume":"8","author":[{"given":"Yoshihiro","family":"Aiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Aishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minae","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhisa","family":"Takatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Abiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"30146_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","volume":"31","author":"S Hohenester","year":"2009","unstructured":"Hohenester, S., Oude-Elferink, R. P. & Beuers, U. Primary biliary cirrhosis. Semin Immunopathol 31, 283\u2013307 (2009).","journal-title":"Semin Immunopathol"},{"key":"30146_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper, E. M. et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136, 1281\u20131287 (2009).","journal-title":"Gastroenterology"},{"key":"30146_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00535-014-0998-z","volume":"50","author":"A Tanaka","year":"2015","unstructured":"Tanaka, A., Hirohara, J., Nakanuma, Y., Tsubouchi, H. & Takikawa, H. Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA. J Gastroenterol 50, 675\u2013682 (2015).","journal-title":"J Gastroenterol"},{"key":"30146_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura, M. et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45, 118\u2013127 (2007).","journal-title":"Hepatology"},{"key":"30146_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone, M. et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology 63, 930\u2013950 (2016).","journal-title":"Hepatology"},{"key":"30146_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers, W. J. et al. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. Gastroenterology 149, 1804\u20131812 e1804 (2015).","journal-title":"Gastroenterology"},{"key":"30146_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26369-6","volume":"8","author":"N Nishida","year":"2018","unstructured":"Nishida, N. et al. NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population. Sci Rep 8, 8071 (2018).","journal-title":"Sci Rep"},{"key":"30146_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0014-5793(98)00964-8","volume":"434","author":"DK Nagler","year":"1998","unstructured":"Nagler, D. K. & Menard, R. Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett 434, 135\u2013139 (1998).","journal-title":"FEBS Lett"},{"key":"30146_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcancer.2014.05.001","volume":"31","author":"J Kos","year":"2015","unstructured":"Kos, J., Vizin, T., Fonovic, U. P. & Pislar, A. Intracellular signaling by cathepsin X: molecular mechanisms and diagnostic and therapeutic opportunities in cancer. Semin Cancer Biol 31, 76\u201383 (2015).","journal-title":"Semin Cancer Biol"},{"key":"30146_CR10","doi-asserted-by":"publisher","first-page":"17471","DOI":"10.1074\/jbc.M112.352781","volume":"287","author":"N Bhutani","year":"2012","unstructured":"Bhutani, N., Piccirillo, R., Hourez, R., Venkatraman, P. & Goldberg, A. L. Cathepsins L and Z are critical in degrading polyglutamine-containing proteins within lysosomes. J Biol Chem 287, 17471\u201317482 (2012).","journal-title":"J Biol Chem"},{"key":"30146_CR11","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1074\/jbc.M110.185348","volume":"286","author":"T Ratovitski","year":"2011","unstructured":"Ratovitski, T., Chighladze, E., Waldron, E., Hirschhorn, R. R. & Ross, C. A. Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem 286, 12578\u201312589 (2011).","journal-title":"J Biol Chem"},{"key":"30146_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/acel.12093","volume":"12","author":"A Hafner","year":"2013","unstructured":"Hafner, A. et al. Neuroprotective role of gamma-enolase in microglia in a mouse model of Alzheimer\u2019s disease is regulated by cathepsin X. Aging Cell 12, 604\u2013614 (2013).","journal-title":"Aging Cell"},{"key":"30146_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.expneurol.2007.01.007","volume":"204","author":"W Wendt","year":"2007","unstructured":"Wendt, W., Zhu, X. R., Lubbert, H. & Stichel, C. C. Differential expression of cathepsin X in aging and pathological central nervous system of mice. Exp Neurol 204, 525\u2013540 (2007).","journal-title":"Exp Neurol"},{"key":"30146_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/path.1820","volume":"207","author":"S Krueger","year":"2005","unstructured":"Krueger, S. et al. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 207, 32\u201342 (2005).","journal-title":"J Pathol"},{"key":"30146_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/pros.20046","volume":"60","author":"DK Nagler","year":"2004","unstructured":"Nagler, D. K. et al. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 60, 109\u2013119 (2004).","journal-title":"Prostate"},{"key":"30146_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jim.2005.11.002","volume":"308","author":"DK Nagler","year":"2006","unstructured":"Nagler, D. K. et al. An enzyme-linked immunosorbent assay for human cathepsin X, a potential new inflammatory marker. J Immunol Methods 308, 241\u2013250 (2006).","journal-title":"J Immunol Methods"},{"key":"30146_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-259","volume":"14","author":"T Vizin","year":"2014","unstructured":"Vizin, T., Christensen, I. J., Wilhelmsen, M., Nielsen, H. J. & Kos, J. Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients. BMC Cancer 14, 259 (2014).","journal-title":"BMC Cancer"},{"key":"30146_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jmcb\/mjt022","volume":"5","author":"H Appelqvist","year":"2013","unstructured":"Appelqvist, H., Waster, P., Kagedal, K. & Ollinger, K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol 5, 214\u2013226 (2013).","journal-title":"J Mol Cell Biol"},{"key":"30146_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","volume":"63","author":"P Gissen","year":"2015","unstructured":"Gissen, P. & Arias, I. M. Structural and functional hepatocyte polarity and liver disease. J Hepatol 63, 1023\u20131037 (2015).","journal-title":"J Hepatol"},{"key":"30146_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.20039","volume":"39","author":"L Wang","year":"2004","unstructured":"Wang, L. & Boyer, J. L. The maintenance and generation of membrane polarity in hepatocytes. Hepatology 39, 892\u2013899 (2004).","journal-title":"Hepatology"},{"key":"30146_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","volume":"33","author":"U Beuers","year":"2001","unstructured":"Beuers, U. et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33, 1206\u20131216 (2001).","journal-title":"Hepatology"},{"key":"30146_CR22","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/onc.2008.310","volume":"27","author":"P Boya","year":"2008","unstructured":"Boya, P. & Kroemer, G. Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434\u20136451 (2008).","journal-title":"Oncogene"},{"key":"30146_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2013.07.040","volume":"82","author":"AH Pislar","year":"2014","unstructured":"Pislar, A. H., Zidar, N., Kikelj, D. & Kos, J. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. Neuropharmacology 82, 121\u2013131 (2014).","journal-title":"Neuropharmacology"},{"key":"30146_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2006.09.005","volume":"29","author":"L Urbanelli","year":"2008","unstructured":"Urbanelli, L. et al. Cathepsin D expression is decreased in Alzheimer\u2019s disease fibroblasts. Neurobiol Aging 29, 12\u201322 (2008).","journal-title":"Neurobiol Aging"},{"key":"30146_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. Electronic address, e. e. e. & European Association for the Study of the, L. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67, 145\u2013172 (2017).","journal-title":"J Hepatol"},{"key":"30146_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/liv.12296","volume":"34","author":"Y Aiba","year":"2014","unstructured":"Aiba, Y. et al. Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver Int 34, 679\u2013688 (2014).","journal-title":"Liver Int"},{"key":"30146_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","volume":"60","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma, Y. et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int 60, 167\u2013174 (2010).","journal-title":"Pathol Int"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30146-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30146-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30146-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:05:18Z","timestamp":1671609918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30146-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30146"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30146-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11808"}}